Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer

Mitsuhiro Yasuda, Fumio Takesue, Sadaaki Inutsuka, Masayuki Honda, Tadahiro Nozoe, Daisuke Korenaga

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background. Although superoxide dismutase (SOD) may play an important role in helping to protect against carcinogenesis or tumor progression, little information is available regarding the clinical evaluation of antioxidant defense in patients with gastric cancer. Methods. Serum SOD activity in 34 patients with gastric cancer was estimated and the data compared with clinicopathological parameters. Results. The mean serum SOD activity in the patients was 15.9% ± 2.6%, which was higher than the value obtained in healthy donors. The serum SOD activity in patients over 70 years of age was 14.5% ± 3.0%, which was significantly lower than the value of 16.6% ± 7.3% in those under 70 years of age (P < 0.01). According to the stage of disease, the reduction in SOD activity in the patients aged over 70 years was significant in those with far advanced tumor, classified as stage IV (P < 0.01), but not in those with stage I-III disease. When the cutoff value for high- and low-SOD groups was determined as 18.0%, based on the median value for serum SOD activity in 15 patients with stage IV gastric cancer, the survival rate of patients with stage IV tumor was significantly higher in the high-SOD group than in the low-SOD group (P < 0.05). Conclusion. These findings suggested that the reduction in serum SOD activity in elderly patients may be due to weakness of the antioxidant defense of the host, thus resulting in a poor prognosis in those with far-advanced (stage IV) gastric cancer.

Original languageEnglish
Pages (from-to)148-153
Number of pages6
JournalGastric Cancer
Volume5
Issue number3
DOIs
Publication statusPublished - Nov 10 2002

Fingerprint

Superoxide Dismutase
Stomach Neoplasms
Serum
Antioxidants
Neoplasms
Carcinogenesis
Survival Rate
Tissue Donors

All Science Journal Classification (ASJC) codes

  • Oncology
  • Gastroenterology
  • Cancer Research

Cite this

Yasuda, M., Takesue, F., Inutsuka, S., Honda, M., Nozoe, T., & Korenaga, D. (2002). Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer. Gastric Cancer, 5(3), 148-153. https://doi.org/10.1007/s101200200026

Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer. / Yasuda, Mitsuhiro; Takesue, Fumio; Inutsuka, Sadaaki; Honda, Masayuki; Nozoe, Tadahiro; Korenaga, Daisuke.

In: Gastric Cancer, Vol. 5, No. 3, 10.11.2002, p. 148-153.

Research output: Contribution to journalArticle

Yasuda, M, Takesue, F, Inutsuka, S, Honda, M, Nozoe, T & Korenaga, D 2002, 'Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer', Gastric Cancer, vol. 5, no. 3, pp. 148-153. https://doi.org/10.1007/s101200200026
Yasuda, Mitsuhiro ; Takesue, Fumio ; Inutsuka, Sadaaki ; Honda, Masayuki ; Nozoe, Tadahiro ; Korenaga, Daisuke. / Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer. In: Gastric Cancer. 2002 ; Vol. 5, No. 3. pp. 148-153.
@article{7ec16507cf1e4114b2f5ed417b83d670,
title = "Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer",
abstract = "Background. Although superoxide dismutase (SOD) may play an important role in helping to protect against carcinogenesis or tumor progression, little information is available regarding the clinical evaluation of antioxidant defense in patients with gastric cancer. Methods. Serum SOD activity in 34 patients with gastric cancer was estimated and the data compared with clinicopathological parameters. Results. The mean serum SOD activity in the patients was 15.9{\%} ± 2.6{\%}, which was higher than the value obtained in healthy donors. The serum SOD activity in patients over 70 years of age was 14.5{\%} ± 3.0{\%}, which was significantly lower than the value of 16.6{\%} ± 7.3{\%} in those under 70 years of age (P < 0.01). According to the stage of disease, the reduction in SOD activity in the patients aged over 70 years was significant in those with far advanced tumor, classified as stage IV (P < 0.01), but not in those with stage I-III disease. When the cutoff value for high- and low-SOD groups was determined as 18.0{\%}, based on the median value for serum SOD activity in 15 patients with stage IV gastric cancer, the survival rate of patients with stage IV tumor was significantly higher in the high-SOD group than in the low-SOD group (P < 0.05). Conclusion. These findings suggested that the reduction in serum SOD activity in elderly patients may be due to weakness of the antioxidant defense of the host, thus resulting in a poor prognosis in those with far-advanced (stage IV) gastric cancer.",
author = "Mitsuhiro Yasuda and Fumio Takesue and Sadaaki Inutsuka and Masayuki Honda and Tadahiro Nozoe and Daisuke Korenaga",
year = "2002",
month = "11",
day = "10",
doi = "10.1007/s101200200026",
language = "English",
volume = "5",
pages = "148--153",
journal = "Gastric Cancer",
issn = "1436-3291",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Prognostic significance of serum superoxide dismutase activity in patients with gastric cancer

AU - Yasuda, Mitsuhiro

AU - Takesue, Fumio

AU - Inutsuka, Sadaaki

AU - Honda, Masayuki

AU - Nozoe, Tadahiro

AU - Korenaga, Daisuke

PY - 2002/11/10

Y1 - 2002/11/10

N2 - Background. Although superoxide dismutase (SOD) may play an important role in helping to protect against carcinogenesis or tumor progression, little information is available regarding the clinical evaluation of antioxidant defense in patients with gastric cancer. Methods. Serum SOD activity in 34 patients with gastric cancer was estimated and the data compared with clinicopathological parameters. Results. The mean serum SOD activity in the patients was 15.9% ± 2.6%, which was higher than the value obtained in healthy donors. The serum SOD activity in patients over 70 years of age was 14.5% ± 3.0%, which was significantly lower than the value of 16.6% ± 7.3% in those under 70 years of age (P < 0.01). According to the stage of disease, the reduction in SOD activity in the patients aged over 70 years was significant in those with far advanced tumor, classified as stage IV (P < 0.01), but not in those with stage I-III disease. When the cutoff value for high- and low-SOD groups was determined as 18.0%, based on the median value for serum SOD activity in 15 patients with stage IV gastric cancer, the survival rate of patients with stage IV tumor was significantly higher in the high-SOD group than in the low-SOD group (P < 0.05). Conclusion. These findings suggested that the reduction in serum SOD activity in elderly patients may be due to weakness of the antioxidant defense of the host, thus resulting in a poor prognosis in those with far-advanced (stage IV) gastric cancer.

AB - Background. Although superoxide dismutase (SOD) may play an important role in helping to protect against carcinogenesis or tumor progression, little information is available regarding the clinical evaluation of antioxidant defense in patients with gastric cancer. Methods. Serum SOD activity in 34 patients with gastric cancer was estimated and the data compared with clinicopathological parameters. Results. The mean serum SOD activity in the patients was 15.9% ± 2.6%, which was higher than the value obtained in healthy donors. The serum SOD activity in patients over 70 years of age was 14.5% ± 3.0%, which was significantly lower than the value of 16.6% ± 7.3% in those under 70 years of age (P < 0.01). According to the stage of disease, the reduction in SOD activity in the patients aged over 70 years was significant in those with far advanced tumor, classified as stage IV (P < 0.01), but not in those with stage I-III disease. When the cutoff value for high- and low-SOD groups was determined as 18.0%, based on the median value for serum SOD activity in 15 patients with stage IV gastric cancer, the survival rate of patients with stage IV tumor was significantly higher in the high-SOD group than in the low-SOD group (P < 0.05). Conclusion. These findings suggested that the reduction in serum SOD activity in elderly patients may be due to weakness of the antioxidant defense of the host, thus resulting in a poor prognosis in those with far-advanced (stage IV) gastric cancer.

UR - http://www.scopus.com/inward/record.url?scp=0036035293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036035293&partnerID=8YFLogxK

U2 - 10.1007/s101200200026

DO - 10.1007/s101200200026

M3 - Article

VL - 5

SP - 148

EP - 153

JO - Gastric Cancer

JF - Gastric Cancer

SN - 1436-3291

IS - 3

ER -